Zobrazeno 1 - 8
of 8
pro vyhledávání: '"P N, Redlich"'
Publikováno v:
Surgery. 126(2)
Although computer-based training (CBT) can enhance didactic instruction, few studies have assessed the efficacy of CBT for basic surgical skills training. This study compares CBT with traditional methods of basic surgical skills training.Sixty-nine n
Publikováno v:
Cancer. 83(3)
Breast carcinoma in males is infrequent, and information regarding the results of modern treatment is limited. Cases of breast carcinoma in males were accrued from multiple hospitals in one region to determine treatment, survival, and prognostic fact
Publikováno v:
Wisconsin medical journal. 95(12)
Long-term results of 41 patients who underwent hepatic resection and early experience with 21 patients treated by hepatic cryosurgery alone or combined with resection for colorectal metastases are presented. Patients treated by resection had three or
Publikováno v:
Wisconsin medical journal. 93(5)
The stage of cancers at the time of diagnosis for 10 major sites of disease from patients treated at two Medical College of Wisconsin teaching hospitals was analyzed from tumor registry data and compared from the years 1983, 1987, and 1991. A trend t
Publikováno v:
Cancer research. 52(18)
The use of bacterial exotoxins may constitute novel adjuncts to treatment of gastrointestinal tract malignancies. Clostridium difficile toxin A was evaluated for its cytotoxic effect in vitro on 24 human cell lines and strains including carcinomas of
Autor:
P N Redlich, S E Grossberg
Publikováno v:
The Journal of Immunology. 143:1887-1893
Human IFN-beta (HuIFN-beta) is a biologically potent protein with both antiviral and antiproliferative activities. To understand better its mode of action, a number of murine mAb were developed against a recombinant (serine-17) HuIFN-beta (rHuIFN-bet
Publikováno v:
Transplantation proceedings. 16(6)
Autor:
P N, Redlich, S E, Grossberg
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 143(6)
Human IFN-beta (HuIFN-beta) is a biologically potent protein with both antiviral and antiproliferative activities. To understand better its mode of action, a number of murine mAb were developed against a recombinant (serine-17) HuIFN-beta (rHuIFN-bet